Identification of SARS‐CoV‐2 Main Protease Inhibitors Using Structure Based Virtual Screening and Molecular Dynamics Simulation of DrugBank Database
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of SARS‐CoV‐2 Main Protease Inhibitors Using Structure Based Virtual Screening and Molecular Dynamics Simulation of DrugBank Database
Authors
Keywords
-
Journal
ChemistrySelect
Volume 6, Issue 20, Pages 4991-5013
Publisher
Wiley
Online
2021-06-19
DOI
10.1002/slct.202100854
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Recent discovery and development of inhibitors targeting coronaviruses
- (2020) Thanigaimalai Pillaiyar et al. DRUG DISCOVERY TODAY
- Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
- (2020) Philippe Colson et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Novel, Self-Assembling Dimeric Inhibitors of Human β Tryptase
- (2020) Sarah F. Giardina et al. JOURNAL OF MEDICINAL CHEMISTRY
- Clobetasol Propionate Is a Heme-Mediated Selective Inhibitor of Human Cytochrome P450 3A5
- (2020) William C. Wright et al. JOURNAL OF MEDICINAL CHEMISTRY
- Reducing mortality from 2019-nCoV: host-directed therapies should be an option
- (2020) Alimuddin Zumla et al. LANCET
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
- (2020) Guangdi Li et al. NATURE REVIEWS DRUG DISCOVERY
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- Molecular Stacking Effect on Small-Molecular Organic Light-Emitting Diodes Prepared with Solution Process
- (2020) Ja Yeon Lee et al. ACS Applied Materials & Interfaces
- Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19
- (2020) Nisha Muralidharan et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
- (2020) Yadi Zhou et al. Cell Discovery
- Candidate drugs against SARS-CoV-2 and COVID-19
- (2020) Dwight L. McKee et al. PHARMACOLOGICAL RESEARCH
- General Theory of Fragment Linking in Molecular Design: Why Fragment Linking Rarely Succeeds and How to Improve Outcomes
- (2020) Haoyu S. Yu et al. Journal of Chemical Theory and Computation
- Relative Binding Affinity Prediction of Charge-Changing Sequence Mutations with FEP in Protein–Protein Interfaces
- (2019) Anthony J. Clark et al. JOURNAL OF MOLECULAR BIOLOGY
- Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia
- (2019) Gerard Minuesa et al. Nature Communications
- Viral Macrodomains: Unique Mediators of Viral Replication and Pathogenesis
- (2018) Anthony R. Fehr et al. TRENDS IN MICROBIOLOGY
- Network-based approach to prediction and population-based validation of in silico drug repurposing
- (2018) Feixiong Cheng et al. Nature Communications
- Predicting Binding Free Energies of PDE2 Inhibitors. The Difficulties of Protein Conformation
- (2018) Laura Pérez-Benito et al. Scientific Reports
- Coronaviruses — drug discovery and therapeutic options
- (2016) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
- (2015) Yahira M. Báez-Santos et al. ANTIVIRAL RESEARCH
- Mechanistic insights of SrtA–LPXTG blockers targeting the transpeptidase mechanism in Streptococcus mutans
- (2015) Chandrabose Selvaraj et al. RSC Advances
- g_mmpbsa—A GROMACS Tool for High-Throughput MM-PBSA Calculations
- (2014) Rashmi Kumari et al. Journal of Chemical Information and Modeling
- Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution
- (2010) Jeremy R. Greenwood et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now